EMvision Historical Income Statement

EMV Stock

1.88 0.05 2.59%

Historical analysis of EMvision Medical income statement accounts such as Depreciation And Amortization of 390.1 K or Interest Expense of 121.5 K can show how well EMvision Medical Devices performed in making a profits. Evaluating EMvision Medical income statement over time to spot trends is a great complementary tool to traditional technical analysis and can indicate the direction of EMvision Medical's future profits or losses.

Cash Flow Balance Sheet Income Statement

Covid

Financial Statement Analysis is much more than just reviewing and examining EMvision Medical Devices latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether EMvision Medical Devices is a good buy for the upcoming year.

Net Income Gross Profit

Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in EMvision Medical Devices. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

About EMvision Income Statement Analysis

EMvision Medical Devices Income Statement consists of revenues and expenses along with the resulting net income or loss. It represents the profit for the accounting period attributable to EMvision Medical shareholders. The income statement also shows EMvision investors and management if the firm made money during the period reported. The result of an income statement is the net income that is calculated after subtracting the expenses from revenue. It is essential to investors both as an absolute measure as well as earnings per share (i.e., EPS).

EMvision Medical Income Statement Chart

At this time, EMvision Medical's Interest Income is comparatively stable compared to the past year. Interest Expense is likely to gain to about 121.5 K in 2024, whereas Selling And Marketing Expenses is likely to drop slightly above 4.4 M in 2024.

Selling General Administrative Selling And Marketing Expenses Total Revenue Gross Profit

Total Revenue

Total revenue comprises all receipts EMvision Medical Devices generated from the sale of its products or services. The total amount of income generated by the sale of goods or services related to the company's primary operations.

Gross Profit

Gross profit is a required income statement account that reflects total revenue of EMvision Medical Devices minus its cost of goods sold. It is profit before EMvision Medical operating expenses, interest payments and taxes. Gross profit is also known as gross margin. The profit a company makes after deducting the costs associated with making and selling its products, or the costs associated with providing its services.

Most accounts from EMvision Medical's income statement are interrelated and interconnected. However, analyzing income statement accounts one by one will only give a small insight into EMvision Medical Devices current financial condition. On the other hand, looking into the entire matrix of income statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in EMvision Medical Devices. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

	2021	2022	2023	2024 (projected)
Depreciation And Amortization	243.3K	342.0K	410.6K	390.1K
Interest Income	15.6K	35.3K	341.2K	358.3K

Depreciation And Amortization Interest Income

EMvision Medical income statement Correlations

	Interest Income	Depreciation And Amortization	Interest Expense	Selling General Administrative	Selling And Marketing Expenses	Total Revenue	Gross Profit	Other Operating Expenses	Operating Income	Net Income From Continuing Ops	Ebit	Research Development	Ebitda	Total Operating Expenses	Income Before Tax	Total Other Income Expense Net	Net Income	Income Tax Expense	Net Interest Income	Reconciled Depreciation
Interest Income		-0.29	0.99	0.47	0.52	0.92	0.93	0.61	0.09	-0.16	0.05	0.73	0.01	0.62	-0.01	-0.18	-0.13	0.28	0.97	0.78
Depreciation And Amortization	-0.29		-0.33	0.4	-0.44	-0.34	-0.3	-0.27	0.24	0.12	0.24	0.04	0.16	-0.26	0.18	0.0	-0.01	0.5	-0.24	-0.38
Interest Expense	0.99	-0.33		0.52	0.6	0.97	0.97	0.68	-0.01	-0.19	0.02	0.74	-0.01	0.69	-0.07	-0.08	-0.16	0.16	0.98	0.87
Selling General Administrative	0.47	0.4	0.52		0.58	0.6	0.63	0.75	-0.41	-0.57	-0.3	0.81	-0.4	0.75	-0.49	-0.09	-0.61	-0.01	0.56	0.58
Selling And Marketing Expenses	0.52	-0.44	0.6	0.58		0.73	0.71	0.97	-0.78	-0.79	-0.68	0.74	-0.7	0.96	-0.8	-0.08	-0.75	-0.53	0.59	0.78
Total Revenue	0.92	-0.34	0.97	0.6	0.73		1.0	0.79	-0.21	-0.3	-0.08	0.76	-0.12	0.79	-0.23	0.01	-0.27	-0.04	0.95	0.94
Gross Profit	0.93	-0.3	0.97	0.63	0.71	1.0		0.79	-0.19	-0.29	-0.07	0.77	-0.11	0.79	-0.22	0.0	-0.27	0.0	0.96	0.94
Other Operating Expenses	0.61	-0.27	0.68	0.75	0.97	0.79	0.79		-0.69	-0.78	-0.61	0.86	-0.65	1.0	-0.74	-0.13	-0.75	-0.38	0.68	0.82
Operating Income	0.09	0.24	-0.01	-0.41	-0.78	-0.21	-0.19	-0.69		0.86	0.85	-0.32	0.86	-0.68	0.96	-0.02	0.83	0.81	-0.01	-0.32
Net Income From Continuing Ops	-0.16	0.12	-0.19	-0.57	-0.79	-0.3	-0.29	-0.78	0.86		0.95	-0.59	0.97	-0.77	0.97	0.37	0.98	0.5	-0.2	-0.29
Ebit	0.05	0.24	0.02	-0.3	-0.68	-0.08	-0.07	-0.61	0.85	0.95		-0.36	0.99	-0.6	0.95	0.46	0.91	0.58	0.04	-0.09
Research Development	0.73	0.04	0.74	0.81	0.74	0.76	0.77	0.86	-0.32	-0.59	-0.36		-0.43	0.87	-0.46	-0.28	-0.61	0.11	0.77	0.73
Ebitda	0.01	0.16	-0.01	-0.4	-0.7	-0.12	-0.11	-0.65	0.86	0.97	0.99	-0.43		-0.64	0.96	0.45	0.95	0.55	0.0	-0.13
Total Operating Expenses	0.62	-0.26	0.69	0.75	0.96	0.79	0.79	1.0	-0.68	-0.77	-0.6	0.87	-0.64		-0.73	-0.14	-0.75	-0.36	0.69	0.82
Income Before Tax	-0.01	0.18	-0.07	-0.49	-0.8	-0.23	-0.22	-0.74	0.96	0.97	0.95	-0.46	0.96	-0.73		0.21	0.95	0.67	-0.08	-0.28
Total Other Income Expense Net	-0.18	0.0	-0.08	-0.09	-0.08	0.01	0.0	-0.13	-0.02	0.37	0.46	-0.28	0.45	-0.14	0.21		0.36	-0.22	-0.01	0.15
Net Income	-0.13	-0.01	-0.16	-0.61	-0.75	-0.27	-0.27	-0.75	0.83	0.98	0.91	-0.61	0.95	-0.75	0.95	0.36		0.39	-0.19	-0.25
Income Tax Expense	0.28	0.5	0.16	-0.01	-0.53	-0.04	0.0	-0.38	0.81	0.5	0.58	0.11	0.55	-0.36	0.67	-0.22	0.39		0.22	-0.21
Net Interest Income	0.97	-0.24	0.98	0.56	0.59	0.95	0.96	0.68	-0.01	-0.2	0.04	0.77	0.0	0.69	-0.08	-0.01	-0.19	0.22		0.84
Reconciled Depreciation	0.78	-0.38	0.87	0.58	0.78	0.94	0.94	0.82	-0.32	-0.29	-0.09	0.73	-0.13	0.82	-0.28	0.15	-0.25	-0.21	0.84

Click cells to compare fundamentals

EMvision Medical Account Relationship Matchups

EMvision Medical income statement Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Interest Income	600.0	46.8K	15.6K	35.3K	341.2K	358.3K
Depreciation And Amortization	3.6M	114.0K	243.3K	342.0K	410.6K	390.1K
Interest Expense	597.0	9.8K	18.1K	35.3K	115.7K	121.5K
Selling General Administrative	1.9M	956.8K	1.3M	1.5M	1.8M	1.5M
Selling And Marketing Expenses	1.5M	6.4M	6.6M	7.0M	6.3M	4.4M
Total Revenue	980.7K	1.7M	4.4M	7.0M	11.2M	11.8M
Gross Profit	1.6M	1.6M	4.1M	6.6M	11.2M	11.8M
Other Operating Expenses	5.1M	10.2M	10.5M	10.9M	12.8M	8.7M
Operating Income	(3.5M)	(10.2M)	(10.5M)	(10.9M)	(1.6M)	(1.7M)
Net Income From Continuing Ops	(3.5M)	(8.4M)	(6.1M)	(3.9M)	(2.7M)	(2.9M)
Ebit	(3.5M)	(9.7M)	(8.1M)	(3.8M)	(2.5M)	(2.6M)
Research Development	2.9M	2.7M	2.3M	2.0M	4.7M	2.8M
Ebitda	(3.5M)	(9.6M)	(7.8M)	(3.5M)	(2.1M)	(2.2M)
Total Operating Expenses	5.1M	10.1M	10.2M	10.6M	12.8M	8.6M
Income Before Tax	(3.5M)	(9.7M)	(8.1M)	(6.4M)	(2.0M)	(2.1M)
Total Other Income Expense Net	(597.0)	(1.4M)	(2.4M)	4.6M	(417.5K)	(396.6K)
Net Income Applicable To Common Shares	(3.5M)	(8.4M)	(6.1M)	(3.9M)	(3.5M)	(3.7M)
Net Income	(5.1M)	(8.4M)	(6.1M)	(3.9M)	(2.7M)	(2.9M)
Income Tax Expense	1.6M	(1.3M)	(2.0M)	(2.5M)	697.7K	732.6K
Net Interest Income	36.4K	37.0K	(2.5K)	84.3K	225.5K	236.8K

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.

Explore Investing Ideas

Additional Tools for EMvision Stock Analysis

When running EMvision Medical's price analysis, check to measure EMvision Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy EMvision Medical is operating at the current time. Most of EMvision Medical's value examination focuses on studying past and present price action to predict the probability of EMvision Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move EMvision Medical's price. Additionally, you may evaluate how the addition of EMvision Medical to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

EMvision Historical Income Statement

About EMvision Income Statement Analysis

EMvision Medical Income Statement Chart

Total Revenue

Gross Profit

EMvision Medical income statement Correlations

EMvision Medical Account Relationship Matchups

High Positive Relationship

High Negative Relationship

EMvision Medical income statement Accounts

Thematic Opportunities

Explore Investment Opportunities

Additional Tools for EMvision Stock Analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Tax Provision	Interest Income
Depreciation And Amortization	Interest Expense
Selling General Administrative	Selling And Marketing Expenses
Total Revenue	Gross Profit
Other Operating Expenses	Operating Income
Net Income From Continuing Ops	Ebit
Research Development	Ebitda
Cost Of Revenue	Total Operating Expenses
Income Before Tax	Total Other Income Expense Net
Net Income Applicable To Common Shares	Net Income
Income Tax Expense	Net Interest Income
Reconciled Depreciation

Gross Profit	+ 1.0	Total Revenue
Total Operating Expenses	+ 1.0	Other Operating Expenses
Interest Expense	+ 0.99	Interest Income
Ebitda	+ 0.99	Ebit
Net Interest Income	+ 0.98	Interest Expense
Net Income	+ 0.98	Net Income From Continuing Ops

Income Before Tax	- 0.8	Selling And Marketing Expenses
Net Income From Continuing Ops	- 0.79	Selling And Marketing Expenses
Net Income From Continuing Ops	- 0.78	Other Operating Expenses
Operating Income	- 0.78	Selling And Marketing Expenses
Total Operating Expenses	- 0.77	Net Income From Continuing Ops
Net Income	- 0.75	Total Operating Expenses